Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/IOLCP stock hub

NSE/IOLCP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/IOLCPis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
28.5B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/IOLCP
In the news

Latest news · NSE/IOLCP

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.3
P25 24.9P50 32.4P75 45.7
Trailing P/E24.6
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC6.8
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/IOLCP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
194
Groups with data
10
Currency
INR
Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
India
Country code
IN
Employees
2,891
Employees Change
114%
Employees Change Percent
4.11
Enterprise value
INR 28.3B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
INE485C01011
Last refreshed
2026-05-10
Market cap
INR 28.5B
Price
INR 97.49
Price currency
INR
Rev Per Employee
7,704,565.89x
Sector
Healthcare
Sic
2833
Symbol
nse/IOLCP
Website
https://www.iolcp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
4.07%
EV Earnings
24.45x
EV/EBIT
17.63x
EV/EBITDA
11.92x
EV/Sales
1.27x
Forward P/E
19.33x
P/B ratio
1.63x
P/E ratio
24.56x
P/S ratio
1.28x
PE Ratio10 Y
20.18x
PE Ratio3 Y
20.03x
PE Ratio5 Y
17.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
7.22%
EBITDA Margin
10.68%
Gross margin
34%
Gross Profit
INR 7.6B
Gross Profit Growth
13.84%
Gross Profit Growth Q
16.96%
Gross Profit Growth3 Y
8.46%
Gross Profit Growth5 Y
-2.77%
Net Income
INR 1.2B
Net Income Growth
19.15%
Net Income Growth Q
0.24%
Net Income Growth Quarters
4%
Net Income Growth Years
0%
Net Income Growth3 Y
3.63%
Net Income Growth5 Y
-24.08%
Pretax Margin
7.1%
Profit Margin
5.2%
Profit Per Employee
INR 400,899
Profitable Years
9
Roa5y
9.3
Roe5y
15.97
ROIC
6.77
Roic5y
17.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
17.15%
Cagr15y
18.65%
Cagr1y
55.19%
Cagr3y
8.43%
Cagr5y
-4.21%
Div CAGR3
7.72%
Div CAGR5
-6.51%
EPS Growth
19.16
EPS Growth Years
0
EPS Growth3 Y
3.65
EPS Growth5 Y
-24.26
Revenue Growth
8.37x
Revenue Growth Q
10.91x
Revenue Growth Quarters
5x
Revenue Growth Years
0x
Revenue Growth3 Y
0.38x
Revenue Growth5 Y
2.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

14
MetricValue
Cash
INR 1.7B
Debt
INR 1.6B
Debt EBITDA
INR 0.67
Debt Equity
INR 0.09
Equity
INR 17.5B
Interest Coverage
15.29
Net Cash
INR 127.7M
Net Cash By Market Cap
INR 0.45
Net Cash Growth
-50.16%
Net Debt EBITDA
INR -0.05
Net Debt Equity
INR -0.01
Tangible Book Value
INR 17.4B
Tangible Book Value Per Share
INR 59.13
WACC
5.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
0.09%
Dividend Growth
25%
Dividend Growth Years
0%
Dividend per share
INR 1
Dividend Years
7
Dividend Yield
1.03%
Ex Div Date
2026-02-17
Last Dividend
INR 1
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
386.76%
1Y total return
55.15%
200-day SMA
88.43
3Y total return
27.47%
50-day SMA
80.53
50-day SMA vs 200-day SMA
50under200
5Y total return
-19.36%
All Time High
179.8
All Time High Change
-45.77%
All Time High Date
2020-08-25
All Time Low
3.03
All Time Low Change
3,117.49%
All Time Low Date
2014-02-06
ATR
3.79
Beta
0.27
Ch YTD
18.51
High
99.24
High52
126.7
High52 Date
2025-09-19
High52ch
-23.03%
Low
96.27
Low52
60.9
Low52 Date
2025-05-09
Low52ch
60.08%
Ma50ch
21.06%
Price vs 200-day SMA
10.24%
RSI
66.06
RSI Monthly
56.21
RSI Weekly
63.13
Sharpe ratio
1.05x
Sortino ratio
2.04
Total Return
1.11%
Tr YTD
20.12
Tr15y
1,201%
Tr1m
24.03%
Tr1w
2.63%
Tr3m
30.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 1.6B
Operating Income Growth
34.8
Operating Income Growth Q
31.61
Operating Income Growth3 Y
6.91
Operating Income Growth5 Y
-22.62
Operating margin
7.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
83,533,715%
Shares Insiders
2.04%
Shares Institutions
1.31%
Shares Qo Q
0.06%
Shares Yo Y
-0.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Average Volume
1,720,360.9x
Bv Per Share
59.6
Ch10y
347
Ch15y
1,094.7
Ch1m
24.03
Ch1w
2.63
Ch1y
53.07
Ch3m
28.97
Ch3y
22.78
Ch5y
-24.38
Ch6m
7.53
Change
-0.33%
Change From Open
-0.82
Close
97.81
Days Gap
0.5
Depreciation Amortization
770,575,000
Dollar Volume
100,950,797.5
Earnings Date
2026-05-15
EBIT
INR 1.6B
EBITDA
INR 2.4B
EPS
INR 3.95
F Score
2
Fiscal Year End
March
Founded
1,986
Graham Number
73.18862
Graham Upside
-24.93
Income Tax
INR 423.5M
Is Primary Listing
0
Last Earnings Date
2026-02-11
Last Report Date
2025-12-31
Last Split Date
2025-03-11
Last Split Type
Forward
Lynch Fair Value
INR 19.85
Lynch Upside
-79.64
Ma150
84.21
Ma150ch
15.77%
Ma20
90.79
Ma20ch
7.38%
Next Earnings Date
2026-05-15
Open
98.3
Payment Date
2026-03-13
Position In Range
41.08
Price Date
2026-05-08
Price EBITDA
INR 11.97
Ptbv Ratio
1.64
Relative Volume
0.6x
Revenue
22,273,900,000x
Tax By Revenue
1.9x
Tax Rate
26.76%
Tr6m
8.99%
Volume
1,035,499
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

NSE/IOLCP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.0%
$1.00 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-6.5%
0 consecutive years of growth
Total shareholder yield
+1.1%
Next ex-dividend date: 2026-02-17
Performance

NSE/IOLCP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+55.1%
S&P 500 1Y: n/a
3Y total return
+27.5%
S&P 500 3Y: n/a
5Y total return
-19.4%
S&P 500 5Y: n/a
10Y total return
+386.8%
S&P 500 10Y: n/a
Ownership

Who owns NSE/IOLCP?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.3%
Share of float held by funds and institutions
Insider ownership
+2.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.1%
Negative means the company is buying back shares.
Technical

NSE/IOLCP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
66.1
Neutral momentum band
Price vs 200-day MA
+10.2%
50/200-day relationship not available
Beta (5Y)
0.27
Less volatile than the market
Sharpe ratio
1.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/IOLCP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/IOLCP stock rating?

nse/IOLCP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/IOLCP analysis?

The full report lives at /stocks/nse/IOLCP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/IOLCP?

The latest report frames nse/IOLCP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/IOLCP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

nse/IOLCP stock profile: metrics, valuation and analysis | وكيل سوق الأسهم بالذكاء الاصطناعي